Navigation Links
China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
Date:3/17/2009 

    Financial Highlights

    -- Fiscal year Revenue up 53.6%, to $50.96 Million, exceeding guidance of
       45%

    -- Fiscal year Net Income up 39.1%, to 17.83 Million

    -- Fiscal year Gross Margin 49.6%, up from 46.9% for 2007

    -- EPS increased 28% reaching $0.44 per share compared to $0.35 for 2007


    Recent and Upcoming Events

    -- Clinical Trials of Novel Antibiotic Combination Approved by SFDA and
       Initiated

    -- SFDA Production Approval Received for Tiopronin Enteric-Coated Capsules
       to treat Hepatitis B

    -- Ant-hypertension drug, Candesartan, Entered Clinical Trials

    -- Dry Power Production Line: Expansion Completed and Operating

HAIKOU CITY, China, March 17 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced financial results for the year ended December 31, 2008.

For the 12 months up to December 31 2008, the Company continuously demonstrated consistent top and bottom line growth and improved financial performance. The increase in company revenue exceeded 53.9%, reaching approximately $50.97 million, compared with $33.19 million of 2007. This rapid growth was accounted for by increases in sales of existing products, and increases in the share of sales by new products. China Pharma is working closely with several pharmaceutical research institutions to develop and further launch more products to meet our customers' needs. Our focus is to create a steady increase to the bottom line. We have seen in the past that the diversified portfolio and distribution channels are keys to company operation. Diligent exploration of potential innovations of the pharmaceutical industry and of the domestic market is essential to create value for our shareholders.

For the year ended December 31 20
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... 19, 2013 The Movement ... neurosurgeons, psychiatrists and urologists with specialists in physical ... works with patients and their family members to ... of life. Patients also have the opportunity to ... research. , “Movement disorders can be relentlessly progressive ...
(Date:6/19/2013)... Could drugs that block the body,s system for repairing ... to health? As unlikely as it may seem, those ... and breast cancers driven by a mutation in BRCA, ... revealed she carries the mutation. The compounds, termed PARP ... the current edition of Chemical & Engineering News ...
(Date:6/19/2013)... Research Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to ... Chairman John B. Mowell said, “To support the ... of Directors has made changes to the Company’s ... advisors.” , The Company announced that ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... University Melvin and Bren Simon Cancer Center will ... health care solutions. WellPoint announced plans in ... to help improve patient care and support physicians ... personalized treatment decisions possible. It is estimated that ...
... the screw. That,s just a part of life for people, ... osteogenesis, a method to correct bone deformities that leave one ... University undergraduates has invented a device they hope will make ... Hospital for Children in Houston, the students came up with ...
... April 23 (HealthDay News) -- It goes without saying that ... they can also be very expensive, an expert warns. ... a person bitten by a venomous snake, said Jill Heatley, ... in College Station. The total cost includes hospitalization, which ...
... SAGE Launch Clinical Psychological Science ,Association for Psychological ... Angeles, CA (April 23, 2012) The Association for ... Clinical Psychological Science , a new peer-reviewed journal focused ... venue for cutting-edge research across a wide range of ...
... and American Associations for Dental Research have published ... articles, titled "Hypoplasia-Associated Severe Early Childhood Caries ... York University College of Dentistry) and "Deciduous Molar ... Elfrink, Academic Centre for Dentistry, Amsterdam) discuss the ...
... Guy, M.D., professor of ophthalmology at Bascom Palmer Eye ... Medicine, has pioneered a novel technological treatment for Leber ... causes rapid, permanent, and bilateral loss of vision in ... Genetic mutations in the mitochondria (part of the ...
Cached Medicine News:Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:Rice University student engineers automate limb lengthening for kids 2Health News:Rice University student engineers automate limb lengthening for kids 3Health News:Cost of Snakebite Therapy May Squeeze Victims' Wallets 2Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 3Health News:Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder 2
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/19/2013)... FRANCISCO , June 19, 2013  It may seem ... possible cure for breast cancer. But these were two of ... Society,s 95 th Annual Meeting & Expo that just ... some are saying this focus by some of the top ... our culture,s obsession with new research that can not only ...
(Date:6/18/2013)...  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), ... and commercialization of novel bile acid therapeutics to treat ... underwritten public offering of 1,730,000 shares of its common ... share.  In addition, Intercept has granted the underwriters a ... shares of common stock. All of the ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Aug. 27 Pharmacopeia,(Nasdaq: PCOP ), ... of novel,small molecule therapeutics, announced today that ... Special Program for Research and Training,in Tropical ... novel antimalarial,agents. Pharmacopeia will receive funding to ...
... have started a phase IIa clinical trial designed to ... C viral infection, one,of the toughest infectious diseases in ... which works as a,regulator of the body,s immune response, ... hepatitis C viral infection. "The drugs currently in ...
Cached Medicine Technology:Drug in New Hepatitis C Clinical Trial 2
... Wampole Laboratories offers a comprehensive line of ... serum and urine in convenient one-step stick ... 2 testing options. Clearview Easy HCG is ... convenient stick format. Clearview HCG II ...
The BioCheck hCG ELISA is intended for the quantitative determination of human chorionic gonadotropin (hCG) concentration in human serum. The assay is for use in the early diagnosis of pregnancy in a...
... preparation of whole blood is mixed continuously ... cation-exchange resin. During this time, HbAo binds ... a filter separator is used to remove ... contains glycohemoglobin. The percent glycohemoglobin is determined ...
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Medicine Products: